Study on Telomerase Activity in Peripheral Blood Mononuclear Cells from Lung Cancer Patients

王勇,胡杰贵,江丰收,胡冰

DOI: https://doi.org/10.3969/j.issn.1672-4992.2008.07.025

2008-01-01

Journal of Modern Oncology

Abstract:Objective:To investigate the expression of telomerase activity (TA) in peripheral blood mononuclear cells (PBMNC) from patients with lung cancer, benign lung diseases and healthy volunteers, and explore its clinical significance. Methods: Telomerase activity was detected using the polymerase chain reaction enzyme-linked immunosorbent (PCR-ELISA) among 15 healthy volunteers, 20 patients with benign lung diseases, and 42 cases of lung cancer. Results: Twenty-nine lung cancer patients (69.05%) were positive for TA, the mean OD level was 0.45±0.37,while only 2 benign lung diseases (10%) showed positive with OD level 0.11±0.06, and all healthy people were negative with OD level 0.08±0.03. TA in lung cancer was significantly higher than that in benign lung diseases and healthy people (P0.005). There was no significant correlation between WBC and TA among three groups. The specificity and sensitivity of TA in lung cancer was 90%, 69.05% respectively. There was positive correlation between TA and clinical stage (r=0.585), but no significant correlation between TA and pathological type adjusted for TNM stage. Conclusion: The positive rate of TA is high in lung cancer patients, TA can be used as a good molecular marker for monitoring lung cancer prognosis and directing therapy.